Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Equities

Clearmind Medicine Inc

Clearmind Medicine Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)1.21
  • Today's Change0.00 / 0.00%
  • Shares traded46.00
  • 1 Year change-74.15%
  • Beta--
Data delayed at least 15 minutes, as of Sep 23 2024 20:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Clearmind Medicine Inc. is a psychedelic pharmaceutical biotech company. The Company is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The Company researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 15 patent families, including 27 granted patents and 24 pending applications. The portfolio spans a range of jurisdictions, including the United States, Europe, India, and China.

  • Revenue in USD (TTM)0.00
  • Net income in USD-8.44m
  • Incorporated2017
  • Employees--
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Galera Therapeutics Inc0.00-29.11m4.31m7.00---------0.5892-0.58920.00-2.540.00----0.00-90.03-83.69-119.01-97.54-----------14.3411.60------5.05---29.84--
Notable Labs Ltd313.00k-16.74m4.39m16.00--0.6103--14.01-2.47-2.470.0460.74390.0176----19,562.50-93.89-52.02-120.26-62.0937.7060.19-5,346.97-3,636.93----0.0405---52.89-11.9365.13---50.69--
CNS Pharmaceuticals Inc0.00-15.97m4.50m3.00---------134.04-134.040.00-2.970.00----0.00-358.12-132.47---185.75---------------------23.42------
Qualigen Therapeutics Inc0.00-9.27m4.51m4.00---------1.66-1.750.00-0.4450.00----0.00-134.64-----------------9.64--------10.22------
Chromocell Therapeutics Corp0.00-8.98m4.61m4.00--4.08-----1.66-1.660.000.1960.00----0.00-440.01-----------------7.200.00-------200.20------
Cingulate Inc0.00-19.10m4.87m13.00--1.30-----141.60-141.600.003.950.00----0.00-368.85-----------------47.380.0042-------33.14------
Clearmind Medicine Inc0.00-8.44m4.91m----1.39-----12.73-12.730.000.87280.00-------133.31-218.20-266.82-488.96-----------2.600.0172-------25.03------
Alaunos Therapeutics Inc7.00k-19.13m5.00m1.00--1.32--713.70-11.95-11.950.00442.360.0004--1.757,000.00-117.34-74.83-143.58-89.57-----273,271.40-10,508.06----0.00---99.83-49.086.86---15.56--
Biostax Corp0.00-1.51m5.02m-----------0.0181-0.01810.00-0.06330.00-------395.44-81.51---------------4.04--------53.32------
Weed Inc0.0057.30k5.20m2.0082.55691.3160.11--0.00050.00050.000.000060.00----0.006.00-385.93---822.37-----------46.080.944------97.93---59.13--
Transcode Therapeutics Inc0.00-17.91m5.30m10.00--1.69-----75.48-75.480.000.1820.00----0.00-334.48-133.14-973.00-181.26-----------90.110.00-------5.59------
Virios Therapeutics Inc0.00-5.30m5.39m4.00--1.72-----0.2603-0.26030.000.1130.00----0.00-119.71-79.80-135.31-89.54------------0.00------56.76------
Windtree Therapeutics Inc0.00-11.38m5.52m15.00--0.5811-----0.7463-0.74630.0017.650.00----0.00-32.86-44.51-40.15-48.38-------94,533.34----0.1612------48.25------
Data as of Sep 23 2024. Currency figures normalised to Clearmind Medicine Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.